Jonathan Norton, DO
Interventional Cardiology · Lebanon, PANPI 1447676473
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Penumbra, Inc. at 52.0% of the total. Reporting peaked in 2024 at $3,131 and has fallen 82.6% since, to $543 in 2025. That places this record below the midpoint for interventional cardiology clinicians in PA, where the typical reported total is $6,486.
Across 31 payments — averaging $135.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$2K
- Shockwave Medical, Inc$766
- Medtronic$532
- Atricure, Inc.$140
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$92
- Boston Scientific$89
- plus $389 from 9 others
What the payments were for
- Travel & lodging$1,97347%
- Food & beverage$1,55337%
- Education$66116%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 5 | $2,179 |
| Shockwave Medical, Inc | 2 | $766 |
| Medtronic | 4 | $532 |
| Atricure, Inc. | 1 | $140 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $92 |
| Boston Scientific | 1 | $89 |
| Novartis | 3 | $84 |
| E.r. Squibb & Sons, L.L.C. | 2 | $54 |
| Scpharmaceuticals Inc. | 1 | $50 |
| Teleflex LLC | 1 | $45 |
| Abbott | 2 | $41 |
| Pfizer | 2 | $37 |
| Davol Inc. | 1 | $32 |
| Terumo Medical Corporation | 1 | $24 |
| Johnson & Johnson | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,187 in reported general payments places this provider in the 30th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 24 | $303 |
| Amlodipine Besylate | 23 | $118 |
| Atorvastatin Calcium | 17 | $96 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Lebanon
- Nishant SethiScranton$1.3M
- Matthew BeckerErie$1M
- William GrayWynnewood$753K
- Jon GeorgePhiladelphia$637K
- Shailendra SinghAllentown$470K
- Sanjog KalraPhiladelphia$444K
- James HarveyChambersburg$442K
- Taisei KobayashiPhiladelphia$384K
- Antonis PratsosBroomall$377K
- Ronald FieldsNew Hope$373K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.